Scientific studies have shown that serum levels of PAI-1, vWF, VE-cad, TM, and VEGF were increased in patients with MetS compared to healthy individuals (Georgieva et al., 2004; Hajiluian et al., 2017; Mazidi et al., 2017; Wang et al., 2018). This evidence concerns the gene VEGFA and metabolic syndrome.